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In vertebral  compression  fractures,  the  potential  of kyphoplasty  for restoring  vertebral  height  is  limited
by the  loss  of restored  height  that occurs  when  the  balloon  is  deﬂated  and  removed.  SpineJack® is  also
inserted  percutaneously  but  is  then  left within  the  vertebral  body  after  its expansion  to reduce  the  frac-
ture,  thus  avoiding  loss  of  correction  before  the  injection  of  cement.  SpineJack® was  used in  77  patients
to  treat  83 recent  VCFs  (55.4%  at L1–L2)  due to  trauma  (59.7%)  or osteoporosis  (40.3%).  Three  (3.9%)  com-
plications  were  recorded,  but  none  was  related  to  SpineJack®: there  was  one case  each  of  symptomaticertebral augmentation
natomic restoration
ertebral fracture reduction
cement  leakage  along  a secondary  pedicular  fracture  line;  infection;  and incipient  device  migration  at
the beginning  of the  learning  curve. The  rate  of adjacent  fractures  was only  2.6%.  The  5-year  outcomes
demonstrate  that  SpineJack® provides  both  immediate  and  long-term  beneﬁts  in terms  of  pain  relief,
functional  recovery,  and maintenance  of vertebral  height  restoration.
Level  of evidence:  IV,  retrospective  study.. Introduction
In patients with vertebral compression fractures (VCFs), non-
perative treatment is often poorly tolerated. Both vertebroplasty
nd kyphoplasty performed percutaneously have been found effec-
ive over the last few years in treating symptomatic VCFs. Although
dverse events are rare with both techniques, vertebroplasty is
ssociated with higher rates of procedure-related complications
nd cement leakage [1–5]. With kyphoplasty, a disadvantage is the
igniﬁcant loss of restored vertebral height that can occur after bal-
oon deﬂation [6]. Newly introduced minimally invasive techniques
nclude the cranio-caudal expandable implant SpineJack® (Vexim,
alma, France), which is designed both to restore the original ver-
ebral shape and to stabilise the fractured vertebra via the injection
f high-viscosity polymethylmethacrylate (PMMA) bone cement
Cohesion®, Vexim). In two studies of cadaver vertebrae, vertebral
eight restoration was signiﬁcantly better with SpineJack® than
ith kyphoplasty [6,7]. We  report our experience acquired with
pineJack® between October 2007 and December 2012.E-mail address: c.renaud1@orange.fr
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1.1. Description of the technical procedure
The percutaneous transpedicular approach with ﬂuoroscopic
guidance is used to insert the SpineJack® (Fig. 1) device into the ver-
tebral body, under the most caudal part of the collapse. Expansion of
the device applies a 500-Newton distraction force to the fracture,
along the cranio-caudal axis, similar to a jack. Device expansion
is achieved using a speciﬁc tool that pulls the two ends of the
implant towards each other, shortening the device and deploy-
ing the central titanium component. A rack-and-pinion system
blocks the expansion of the implant at the desired height, while
preventing any loss of correction before the injection of PMMA,
which envelops the implants, ensuring deﬁnitive stabilisation of
the fracture (Fig. 2). In our case-series, although two generations
of the SpineJack® device were used (SpineJack® G1 and SpineJack®
G2), the same operative technique was  followed in every case. The
main technological difference between the two  generations is that
the most recent version has a rack-and-pinion system along the
implant retraction axis, to prevent loss of correction after fracture
reduction. Fig. 3 illustrates the results obtained on an A3.1 fracture
of L1.1.2. Clinical case-series
The case-series included 77 patients with a mean age of 60.9
years and 83 VCFs treated with 164 SpineJack® devices. Of the 83
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wFig. 1. The SpineJack® implant before and after expansion.
ractures, 51 were due to trauma and 32 to osteoporosis. The time
o surgery was less than 15 days in 74.4% of cases. The procedure
as performed on a single vertebral body in 71 patients and on two
ertebral bodies in 6 patients. The distribution of fracture types in
he Magerl classiﬁcation was as follows: A1, 47.2% (A1.2, 30%); A2,
1.4%; and A3.1, 11.4%. The most frequently affected levels were
1 (32.5%), L2 (22.9%), and T12 (16.9%). Mean hospital stay length
as 3.7 days and mean follow-up was 35 months (6 to 67 months).
ain relief was statistically signiﬁcant (P < 0.001), with a pain score
ecrease from 7.9 pre-operatively to 1.8 post-operatively (Fig. 4).
No complications related to the SpineJack® device
ere recorded. Of the 77 patients, 3 (3.9%) experienced
Fig. 2. Mechanism of action of
Fig. 3. 64-year-old woman with a post-traumatic type A3.1 fracture of L1rgery & Research 101 (2015) 857–859
procedure-related complications. The only case of device migration
reﬂected a technical problem that occurred with an instrument
prototype. Post-operative computed tomography (CT) scans
showed cement leakage in 11 patients, all of whom had post-
traumatic fractures (21.6% of traumatic fractures). Symptoms were
present in a single patient, who had nerve root pain due to leakage
of the cement along a secondary fracture line in the pedicle. No
recurrent compression fractures developed at the treated sites.
Adjacent fractures occurred in 2.6% of cases. No re-operations were
needed on treated vertebrae. One patient experienced a nosoco-
mial skin infection that was probably due to contamination from
an oral infection and had a favourable outcome after antibiotic
therapy.
2. Discussion
The results of this 5-year retrospective study show that the
SpineJack® procedure is effective for the management of high- and
medium-energy fractures. Fracture reduction and stabilisation by
combining SpineJack® implantation and cement injection consis-
tently produced immediate improvements.
The visual analogue scale (VAS) pain score showed a signiﬁcant
decline, which occurred rapidly and proved long-lasting. The pain
score improvement was  77% at hospital discharge and increased
 the SpineJack® implant.
. Computed tomography before and after the SpineJack® procedure.
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digitation and bone-cement interface after augmenting fractured vertebrae: aFig. 4. Pain score changes over time.
radually to 86% after 1 year. These gains are far greater than the
3% score decrease considered to be clinically signiﬁcant [8]. The
6% improvement after 1 year was larger than the improvements
een in a study comparing kyphoplasty to the KIVA® VCF system
68% and 67%, respectively) [9]. The VAS score showed a greater
ean decrease (6.9 points after 1 year) than reported previously
ith vertebroplasty and kyphoplasty (mean 4–5 point decrease for
oth procedures) [4].
This study establishes the safety of the minimally invasive
pineJack® procedure. Thus, only 3 (3.9%) patients experienced
rocedure-related complications and a single patient had a super-
cial infection. The cement leakage rate in the subgroup with
ost-traumatic VCFs (21.6%) was similar to that reported by
aestretti et al. (6/33 fractures, 18.8%) [10]. This result may  be
scribable to the very good diffusion of the cement in the verte-
ra, from one endplate across to the other, along the trabecular
etwork restored by reducing the fracture [11]. The rates of adja-
ent fractures were 2.4% of treated fractures and 2.6% of patients,
.e., considerably lower than the 10% to 22% rates reported with
ertebroplasty and kyphoplasty [3,12].. Conclusion
This study establishes the effectiveness of the SpineJack® proce-
ure, which provides immediate and long-lasting pain relief, as well
[rgery & Research 101 (2015) 857–859 859
as a rapid return to self-sufﬁciency. The complication rate is similar
to that seen with other vertebral expansion methods, whereas the
risk of adjacent fractures is very low.
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